• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Livent Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    12/27/23 5:24:17 PM ET
    $LTHM
    Major Chemicals
    Industrials
    Get the next $LTHM alert in real time by email
    false 0001742924 0001742924 2023-12-20 2023-12-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

    UNITED STATES

     SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the 

    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): December 27, 2023 (December 20, 2023)

     

     

     

    LIVENT CORPORATION

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-38694   82-4699376

    (State or other jurisdiction of

    incorporation or organization)

      (Commission File Number)  

    (I.R.S. Employer

    Identification No.)

             

    1818 Market Street

    Philadelphia, Pennsylvania

          19103
    (Address of principal executive offices)       (Zip Code)

     

    Registrant’s telephone number, including area code: 215-299-5900

     

     

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, par value $0.001 per share LTHM New York Stock Exchange

     

    Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

    Item 1.01Entry into a Material Definitive Agreement.

     

    Amendment to the Transaction Agreement

     

    On December 20, 2023, Livent Corporation, a Delaware corporation (the “Company” or “Livent”), entered into the Third Amendment (the “Amendment”) to the previously disclosed Transaction Agreement, dated as of May 10, 2023 (the “Transaction Agreement”), by and among Livent, Arcadium Lithium plc, a public limited company incorporated under the laws of the Bailiwick of Jersey (originally known as Lightning-A Limited, a private limited company incorporated under the laws of the Bailiwick of Jersey and f/k/a Allkem Livent plc) (“Arcadium”), and Allkem Limited, an Australian public company limited by shares (“Allkem”), and subsequently joined by Lightning-A Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Arcadium Lithium Intermediate IRL Limited, a private company limited by shares and incorporated and registered in Ireland, and subsequently amended by that certain Amendment to Transaction Agreement, dated as of August 2, 2023, by and between Livent and Allkem and that certain Second Amendment to Transaction Agreement, dated as of November 5, 2023, by and between Livent and Allkem. The Transaction Agreement contemplates that (i) Arcadium will acquire all of the shares of Allkem pursuant to a scheme of arrangement under the Corporations Act (Cth) 2001 of Australia (the “Scheme”), resulting in Allkem becoming a wholly owned subsidiary of Arcadium, and (ii) Merger Sub, a wholly owned subsidiary of Arcadium, will merge with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Arcadium (the “Merger”).

     

    Under the Amendment, Livent and Allkem have agreed to amend the Transaction Agreement to modify the forms of Memorandum of Association and Articles of Association of Arcadium in Exhibit E to the Transaction Agreement (i) to remove provisions relating to additional information that may be requested by Arcadium from shareholders nominating directors or proposing other business at meetings of Arcadium shareholders, and (ii) to provide that directors may be removed by shareholders with or without cause. All other terms of the Transaction Agreement remain unmodified and in full force and effect in accordance therewith.

     

    The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is attached hereto as Exhibit 2.1 and is incorporated herein by reference.

     

    Item 9.01 Financial Statements and Exhibits

     

    Exhibits

     

         

    Exhibit     

    No.

      Description
       
       
    2.1   Third Amendment to Transaction Agreement, dated as of December 20, 2023, by and between Livent Corporation, a Delaware corporation, and Allkem Limited, an Australian public company limited by shares.

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      LIVENT CORPORATION
       
       
      By: /s/ Gilberto Antoniazzi
       

    Name:

    Title:

     

    Gilberto Antoniazzi

    Vice President and Chief Financial Officer

    Dated: December 27, 2023

     

     

     

     

    Get the next $LTHM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LTHM

    DatePrice TargetRatingAnalyst
    12/5/2023$18.00 → $15.00Neutral → Underweight
    Piper Sandler
    10/25/2023$33.00 → $19.00Overweight → Neutral
    Piper Sandler
    10/25/2023$27.00 → $21.00Hold → Buy
    Deutsche Bank
    5/11/2023$32.00Neutral → Buy
    B. Riley Securities
    5/11/2023$30.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/5/2023$29.00 → $27.00Neutral → Buy
    BofA Securities
    2/16/2023$26.00 → $29.00Buy → Neutral
    BofA Securities
    1/11/2023$26.00Underperform → Buy
    BofA Securities
    More analyst ratings

    $LTHM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Daloia G Peter returned 207,180 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Livent Corp. (0001742924) (Issuer)

      1/8/24 4:18:29 PM ET
      $LTHM
      Major Chemicals
      Industrials
    • Brondeau Pierre R returned 405,421 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Livent Corp. (0001742924) (Issuer)

      1/8/24 4:16:54 PM ET
      $LTHM
      Major Chemicals
      Industrials
    • Pallash Robert C returned 79,977 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Livent Corp. (0001742924) (Issuer)

      1/8/24 4:14:24 PM ET
      $LTHM
      Major Chemicals
      Industrials